Does MEPOLIZUMAB Cause Pustular psoriasis? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Pustular psoriasis have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.1% of all adverse event reports for MEPOLIZUMAB.
21
Reports of Pustular psoriasis with MEPOLIZUMAB
0.1%
of all MEPOLIZUMAB reports
20
Deaths
21
Hospitalizations
How Dangerous Is Pustular psoriasis From MEPOLIZUMAB?
Of the 21 reports, 20 (95.2%) resulted in death, 21 (100.0%) required hospitalization, and 20 (95.2%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
Which MEPOLIZUMAB Alternatives Have Lower Pustular psoriasis Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE